Related Experiment Video
Updated: Mar 17, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
[Hypertriglyceridemia and ischemic heart disease: Is a risk factor ?]
Insights
This study found no significant difference in triglyceride levels between patients with and without coronary cardiovascular disease (CVD). Elevated triglycerides are not definitively linked to increased CVD risk in this patient cohort.
Area of Science:
- Cardiology
- Lipid Metabolism
- Public Health
Background:
- Hypercholesterolemia is a known risk factor for coronary cardiovascular disease (CVD).
- The association between triglyceride levels and CVD risk is debated.
- Understanding lipid profiles is crucial for cardiovascular risk assessment.
Purpose of the Study:
- To investigate triglyceride levels in patients with and without CVD.
- To examine the relationship between triglycerides, cholesterol, HDL, LDL, obesity, and overweight.
- To clarify the role of triglycerides in cardiovascular risk.
Main Methods:
- Retrospective study of 100 patients (30-60 years old) between January and December 2009.
- Included patients with and without CVD from Córdoba Hospital and Clínica Sucre.
- Compared lipid profiles, including triglycerides, HDL, and LDL cholesterol, between CVD and control groups.
Main Results:
- No statistically significant differences in lipid values were observed between groups.
- Triglyceride levels were slightly higher in the control group, but not statistically significant (p=0.7162).
- The study included 64 patients with CVD and 36 controls, with 74% males and 68% over 50 years old.
Conclusions:
- Triglyceride levels did not show a statistically significant elevation in patients with CVD.
- The findings suggest that triglycerides may not be a primary risk factor for CVD in this population.
- Further research is needed to fully elucidate the complex role of triglycerides in cardiovascular health.
Unlabelled:
Hypercholesterolemia is a well known risk factor for coronary cardiovascular disease (CVD). However, the role of triglycerides in CVD risk remains controversial.
Objective:
to study triglyceride level and its relationship with Cholesterol, HDL and LDL Cholesterol level, obesity and overweight in patients with and without CVD.
Material And Methods:
we retrospectively studied patients with and without CVD who attended to Córdoba Hospital and Cardiology unit of Clínica Sucre at Córdoba city between 1st January to 31 st of December of 2009. We included patients with age between 30 to 60 years old with CVD and a control group.
Results:
100 patients were included, 64 with CVD and 36 as a control group. 74% were male and 68% older than 50 years old. Lipid values were not statistically significant in both groups. Triglyceride level was higher in the control group, although the difference was not statistically significant (p=0, 7162).
Conclusion:
Triglyceride level was not higher in patients with CVD.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Coronary Artery Disease I: Introduction

